Loading...
Role of Immune Checkpoint Inhibitors in Advanced or Recurrent Endometrial Cancer
Currently, treatment options for patients with advanced or recurrent endometrial cancer remain limited. The current standard of care treatment for advanced endometrial carcinoma is a platinum doublet chemotherapy. Second-line treatment options overall are very limited. There is no optimal treatment...
Na minha lista:
| Udgivet i: | Cureus |
|---|---|
| Main Authors: | , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Cureus
2018
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6015998/ https://ncbi.nlm.nih.gov/pubmed/29942724 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7759/cureus.2521 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|